On July 18, 2022, AIM ImmunoTech Inc announced that it has received a notice from Jonathan Jorgl, nominating Robert Chioini and Michael Rice to the Company board. In addition, the Company stated that it filed a case against Jonathan Jorgl regarding the individuals have failed to register as a group pursuant to U.S. securities laws and have committed other unlawful actions in the context of their attempt to effectuate a takeover of the Company's Board.